Chinese herbal medicine may improve outcomes after STEMI

CHICAGO — A drug derived from traditional Chinese medicine as an adjunct to guideline-directed therapy improved CV outcomes at 30 days and 1 year compared with placebo after revascularization, with no excess bleeding risk, a speaker reported.“Despite reperfusion and optimal medical therapy, patients with STEMI still face a high risk of in-hospital mortality, myocardial no-flow and

2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association

Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction

Traditional Chinese medicine found to decrease post-heart-attack risk

The role of cardiac rehabilitation in improving cardiovascular outcomes

Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China

Frontiers The known, unknown, and the intriguing about members of a critically endangered traditional medicinal plant genus Aconitum

Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines

Frontiers Autophagy Modulators From Chinese Herbal Medicines: Mechanisms and Therapeutic Potentials for Asthma

Frontiers Intervention effects of traditional Chinese medicine on stem cell therapy of myocardial infarction